Status:
RECRUITING
Quality of Life and Stigmatization in Children with Congenital Melanocytic Nevi Before and After Nevus Excision
Lead Sponsor:
University Children's Hospital, Zurich
Conditions:
Quality of Life
Stigmatization
Eligibility:
All Genders
9-16 years
Brief Summary
Congenital melanocytic nevi (CMN) are a quite common congenital disorder. Over years, surgical excision was proposed to the patients because transformation into a malignant skin tumor (melanoma) was f...
Detailed Description
All children with CMN that will have their nevus removed in our surgical department will be asked to participate. The investigators will send a package of questionnaires to evaluate quality of life an...
Eligibility Criteria
Inclusion
- patients with a congenital melanocytic nevi of at least 2 cm2 that will be removed surgically
- age between 9 months and 16 years
Exclusion
- mental retardation of the child
- insufficient knowledge of the German language of both parents
- severe comorbidities
- previous therapies done for the CMN (dermabrasion, surgery, laser)
Key Trial Info
Start Date :
May 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2031
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT02280889
Start Date
May 1 2013
End Date
December 1 2031
Last Update
January 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Children's Hospital Zurich, Division of Pediatric Plastic and reconstructive Surgery
Zurich, Switzerland, 8008